We have lawyers on the Best Lawyers of America List, The Legal 500, ranked Chambers USA top Healthcare: Pharmaceutical/Medical Products Regulatory practices, and Washington D.C. Super Lawyers list.
We have lawyers who have been the LMG Life Science’s Life Sciences Star and on International Who’s Who of Life Science Lawyers.
Hogan Lovells Publications
05 April 2019
Hogan Lovells has been at the forefront of advising our clients on the clearance or approval of an increasing number of software as a medical device (SaMD) products and other medical...
Hogan Lovells Publications
24 January 2019
Thirty-two days into the longest government shutdown in U.S. history, the Food and Drug Administration (FDA or the agency) announced two developments signaling further headway toward...
Hogan Lovells Publications
20 December 2018
On 17 December 2018 the U.S. Food and Drug Administration (FDA) issued a final guidance document intended to help manufacturers determine the appropriate premarket approval (PMA)...
Hogan Lovells Publications
12 December 2018
Last week the Food and Drug Administration (FDA) issued a proposed set of new regulations to further define and update the De Novo review process. Although De Novo review has been available ...
Hogan Lovells Publications
11 December 2018
Hogan Lovells Publications
28 November 2018
